First Time Loading...

Apollo Endosurgery Inc
NASDAQ:APEN

Watchlist Manager
Apollo Endosurgery Inc Logo
Apollo Endosurgery Inc
NASDAQ:APEN
Watchlist
Price: 10 USD Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

APEN Price Targets Summary
Apollo Endosurgery Inc

There are no price targets for APEN.
APEN Lowest Forecast
Wall Street Target
Not Available
APEN Average Forecast
Wall Street Target
Not Available
APEN Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Apollo Endosurgery Inc Competitors:
Price Targets
AXNX
Axonics Inc
9% Upside
ISRG
Intuitive Surgical Inc
13% Upside
M
301363
Mehow Innovative Ltd
46% Upside
ARJO B
Arjo AB (publ)
17% Upside
AXNX
Axonics Inc
9% Upside
ISRG
Intuitive Surgical Inc
13% Upside
M
301363
Mehow Innovative Ltd
46% Upside
ARJO B
Arjo AB (publ)
17% Upside
BFLY
Butterfly Network Inc
231% Upside
J
287410
Jeisys Medical Inc
35% Upside
IDXX
IDEXX Laboratories Inc
28% Upside
3600
Modern Dental Group Ltd
44% Upside

Revenue
Forecast

Revenue Estimate
Apollo Endosurgery Inc

For the last 8 years the compound annual growth rate for Apollo Endosurgery Inc's revenue is 40%. The projected CAGR for the next 3 years is 34%.

40%
Past Growth
34%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Apollo Endosurgery Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Apollo Endosurgery Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
What are analyst estimates?

See Also

Summary
APEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
APEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
APEN stock valuation using valuation multiples.
Wall Street Estimates
APEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
APEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is APEN's stock price target?
Not Available

APEN doesn't have any price targets made by Wall Street professionals.

What is Apollo Endosurgery Inc's Revenue forecast?
Projected CAGR
34%

For the last 8 years the compound annual growth rate for Apollo Endosurgery Inc's revenue is 40%. The projected CAGR for the next 3 years is 34%.

ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.